| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.17 | 0.4 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | 0.16 | 0.4 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.043 | 0.4 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.17 | 0.4 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |